ENTITY
Immunovant Inc

Immunovant Inc (IMVT US)

8
Analysis
Health Care • United States
Immunovant Inc operates as a biopharmaceutical company. The Company offers discovers and manufactures drugs for patients with autoimmune diseases. Immunovant serves customers worldwide.
more
Exchange Announcement • 06 Aug 2026 19:29

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 06 Aug 2026 19:15

Current Report (Form 8-K | Period ending 2026-08-06)

Exchange Announcement • 23 Jul 2026 04:19

Annual Report to Security Holders (Form ARS | Period ending 2026-03-31)

Exchange Announcement • 20 May 2026 19:28

Annual Report (Form 10-K | Period ending 2026-03-31)

Exchange Announcement • 20 May 2026 19:14

Current Report (Form 8-K | Period ending 2026-05-20)

x